SCHEMBL30490412

SCHEMBL30490412

CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 17/20 0.52
▸ NPY1R P25929 10/20 0.52
▸ NPY5R Q15761 9/20 0.52
▸ NPY2R P49146 6/20 0.52
▸ APLNR P35414 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30645267 0.98 NPY4R (0.53) NPY4RNPY1RNPY5RNPY2RAPLNR
SCHEMBL30645279 0.95 NPY4R (0.51) NPY4RNPY1RNPY5RNPY2RAPLNR
SCHEMBL1071080 0.94 NPY4R (0.43) NPY4RNPY1RNPY5RNPY2R
SCHEMBL1071076 0.94 NPY4R (0.43) NPY4RNPY1RNPY5RNPY2R
SCHEMBL29588409 0.94 NPY4R (0.43) NPY4RNPY1RNPY5RNPY2R
SCHEMBL30525411 0.93 NPY4R (0.44) NPY4RNPY1RNPY5RNPY2R
SCHEMBL9294926 0.92 NPY4R (0.50) NPY4RNPY1RNPY5RNPY2R
SCHEMBL29948315 0.91 C5AR1 (0.46) NPY4RNPY1RNPY5RNPY2R
SCHEMBL30851295 0.91 NPY4R (0.52) NPY4RNPY1RNPY5RNPY2RAPLNR
SCHEMBL31567997 0.91 NPY4R (0.52) NPY4RNPY1RNPY5RNPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116617166-A Polypeptide modified liposome for targeted treatment of glioblastoma and preparation and application thereof 中国科学院近代物理研究所 2023-08-22 — — CN disclosed
CN-116606346-A Preparation and application of polypeptide ligand and radioactive molecular probe for brain glioma diagnosis 中国科学院近代物理研究所 2023-08-18 — — CN disclosed
Send feedback